Vital Farms, Inc. has recently released its 10-Q report, providing an in-depth look into the company's financial condition and operations. The Austin, Texas-based food company is primarily focused on packaging, marketing, and distributing shell eggs, butter, and other products in the United States. Vital Farms sources its products from animals raised on family farms, with a strong emphasis on animal welfare and sustainable farming practices.
In the 10-Q report, Vital Farms highlighted its mission to bring ethical food to the table, setting itself apart by raising the standards in the food industry and disrupting industrial, factory food norms. The company has positioned itself as the leading U.S. brand of pasture-raised eggs and the second-largest U.S. egg brand by retail dollar sales. Vital Farms is committed to Conscious Capitalism, prioritizing positive, long-term outcomes with all stakeholders, including farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders.
The company sources its eggs from a network of 575 contracted family farms, along with a small number of company-owned "accelerator farms." Vital Farms has strategically designed its supply chain to ensure high production standards and optimal year-round operation. The company works with contracted family farms under buy-sell contracts, where the farmer is responsible for all working capital and investments required to produce the eggs and manage the farm.
Vital Farms has experienced consistent sales growth, reporting net revenue of $198.9 million and $145.0 million, net income of $16.4 million and $7.4 million, and Adjusted EBITDA of $27.4 million and $15.2 million in the 13-week periods ended September 28, 2025 and September 29, 2024, respectively. For the 39-week periods ended September 28, 2025 and September 29, 2024, the company reported net revenue of $545.9 million and $440.3 million, net income of $50.0 million and $42.8 million, and Adjusted EBITDA of $84.8 million and $67.6 million, respectively.
The report also outlined certain known trends, events, and uncertainties that could impact Vital Farms' business, including the potential effects of agricultural diseases such as Highly Pathogenic Avian Influenza (HPAI) and economic uncertainty and volatility. The company is closely monitoring these factors and working to mitigate potential disruptions to its product supplies.
With cash, cash equivalents, and marketable securities of $145.1 million as of September 28, 2025, and $60.0 million available under its syndicated revolving credit facility agreement, Vital Farms anticipates having sufficient liquidity to make investments in its business to support its long-term growth strategy. The company expects that its cash, cash equivalents, marketable securities, and cash provided by operating activities will be sufficient to fund its operating expenses for at least the next 12 months and to make investments in its business in support of its long-term growth strategy.
Today the company's shares have moved -2.04% to a price of $32.18. For the full picture, make sure to review Vital Farms's 10-Q report.
